Perseus Proteomics Inc
TSE:4882
Cash Flow Statement
Cash Flow Statement
Perseus Proteomics Inc
| Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(597)
|
(686)
|
(785)
|
(1 056)
|
(1 103)
|
(964)
|
(902)
|
(787)
|
|
| Depreciation & Amortization |
3
|
5
|
6
|
6
|
3
|
4
|
3
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
41
|
0
|
7
|
0
|
|
| Other Non-Cash Items |
135
|
192
|
127
|
198
|
201
|
123
|
81
|
(18)
|
|
| Cash Taxes Paid |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Change in Working Capital |
(18)
|
(39)
|
88
|
78
|
64
|
156
|
99
|
122
|
|
| Cash from Operating Activities |
(477)
N/A
|
(528)
-11%
|
(564)
-7%
|
(773)
-37%
|
(834)
-8%
|
(682)
+18%
|
(719)
-6%
|
(683)
+5%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(34)
|
(183)
|
(171)
|
(153)
|
(159)
|
(73)
|
(75)
|
(29)
|
|
| Other Items |
0
|
(0)
|
(42)
|
(33)
|
9
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(34)
N/A
|
(183)
-442%
|
(213)
-16%
|
(186)
+12%
|
(150)
+19%
|
(73)
+51%
|
(75)
-3%
|
(29)
+62%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
2 652
|
(0)
|
(0)
|
0
|
64
|
993
|
932
|
0
|
|
| Other |
(5)
|
0
|
0
|
0
|
(0)
|
(9)
|
(9)
|
(0)
|
|
| Cash from Financing Activities |
2 648
N/A
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
64
N/A
|
984
+1 439%
|
923
-6%
|
3
-100%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
9
|
25
|
7
|
5
|
17
|
(9)
|
(2)
|
7
|
|
| Net Change in Cash |
2 146
N/A
|
(686)
N/A
|
(770)
-12%
|
(954)
-24%
|
(904)
+5%
|
220
N/A
|
126
-43%
|
(701)
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(511)
N/A
|
(711)
-39%
|
(735)
-3%
|
(926)
-26%
|
(993)
-7%
|
(755)
+24%
|
(795)
-5%
|
(711)
+10%
|
|